Wilson Sonsini Goodrich & Rosati and Bär & Karrer have advised Revival Healthcare Capital on the deal. Walder Wyss has advised Distalmotion. Distalmotion SA, a global...
Distalmotion Secures $150 Million Series G Financing Led by Revival Healthcare Capital
Mosanna Therapeutics Completes USD 80 Million Series A Funding Round
VISCHER has advised Mosanna Therapeutics AG; Walder Wyss advised EQT Life Sciences. Mosanna Therapeutics AG has successfully closed its USD 80 million Series A funding round....
TransPerfect’s Acquisition of Apostroph Group
Walder Wyss advised TransPerfect; the Apostroph Group stakeholders were represented by KPMG, Milbank, Advestra, and Baker McKenzie. TransPerfect, the world’s largest provider of language and AI...
KARL STORZ’s Acquisition Of Anklin
Walder Wyss advised the Anklin family on the deal. The Swiss company Anklin, based in Reinach, is now part of the KARL STORZ direct sales network,...
SixPeaks Bio AG’s $110 Million Series A Financing Round
Walder Wyss advised SixPeaks Bio AG while Lenz & Staehelin acted as Swiss counsel to AstraZeneca. SixPeaks Bio AG has secured USD30 million in Series A...
Axalta Coating Systems Group’s Acquisition of Andre Koch AG
Walder Wyss advised Axalta Coating Systems on this transaction. Axalta Coating Systems Group (NYSE: AXTA) acquired André Koch AG, an established provider of car repair and...
Boehringer Ingelheim’s CHF450 Million Acquisition of T3 Pharmaceuticals AG
Walder Wyss advised Boehringer Ingelheim in the transaction. Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
Nouscom’s €67.5 Million Oversuscribed Series C Financing Round
Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction. Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized...
CONVOTIS GmbH’s Acquisition of Acdalis AG
Walder Wyss advised CONVOTIS on all aspects of Swiss law on the transaction. CONVOTIS strengthens its position in Switzerland with the acquisition of acdalis AG, a...
Pierre Fabre Laboratories’ Acquisition of Vertical Bio AG
Walder Wyss advised Versant Ventures on this transaction. ierre Fabre Laboratories, the French pharmaceutical and dermo-cosmetic company, announced the acquisition of Vertical Bio AG, a developer...
Skribble AG’s €10 Million Series A Funding Round
Walder Wyss advised Acton and VI Partners on this financing round. Specialist for electronic signatures Skribble AG, based in Zurich, has completed a round of funding...